RecruitingNot ApplicableNCT05904548

Atrial Flutter Ablation in the iCMR

Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter

Sponsor

Imricor Medical Systems

Enrollment

91 participants

Start Date

Jun 20, 2024

Study Type

INTERVENTIONAL

Conditions

Atrial Flutter Typical

Summary

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called RF Ablation for people with atrial flutter typical. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERF Ablation

RF ablation for type I atrial flutter under iCMR guidance

Locations(6)

Johns Hopkins University (JHU)

Baltimore, Maryland, United States

University of Virginia (UVA)

Charlottesville, Virginia, United States

Virginia Commonwealth University

Richmond, Virginia, United States

l'institut Cardiologique Paris Sud (ICPS)

Massy, France

Amsterdam University Medical Center (AUMC)

Amsterdam, Netherlands

University Hospital of Vaud (CHUV)

Lausanne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05904548

Related Trials

Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation

NCT046782581 location